Incredibly, the FDA ruled that Covid-19 boosters that will be updated for the Omicron variant will require zero clinical data to be submitted, that is, there will be zero transparency and accountability to prove that an injectible, experimental gene product is either safe or effective. Science is dead, and Big Pharma has carte blanche authority over regulatory processes meant to ensure public safety.
“I actually think that this fall we have to go all out on our booster campaign,” said Dr. Peter Marks, head of the agency’s Center for Biologics Evaluation and Research.
Original article
